RxSight, Inc. (NASDAQ: RXST) reported Q4 EPS of ($0.45), $0.30 better than the analyst estimate of ($0.75). Revenue for the quarter came in at $16.1 million versus the consensus estimate of $15.78 million.

For earnings history and earnings-related data on RxSight, Inc. (RXST) click here.